COPD and Cardiovascular Disease
Open accessThe DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
Abstract
COPD is one of the major public health problems in people aged 40 years or above. It is currently the 4th leading cause of death in the world and projected to be the 3rd leading cause of death by 2020. COPD and cardiac comorbidities are frequently associated. They share common risk factors, pathophysiological processes, signs and symptoms, and act synergistically as negative prognostic factors. Cardiac disease includes a broad spectrum of entities with distinct pathophysiology, treatment and prognosis. From an epidemiological point of view, patients with COPD are particularly vulnerable to cardiac disease. Indeed, mortality due to cardiac disease in patients with moderate COPD is higher than mortality related to respiratory failure. Guidelines reinforce that the control of comorbidities in COPD has a clear benefit over the potential risk associated with the majority of the drugs utilized. On the other hand, the true survival benefits of aggressive treatment of cardiac disease and COPD in patients with both conditions have still not been clarified. Given their relevance in terms of prevalence and prognosis, we will focus in this paper on the management of COPD patients with ischemic coronary disease, heart failure and dysrhythmia.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Chronic Obstructive Pulmonary Disease
Barnes, P. J. (2000) · New England Journal of Medicine · doi:10.1056/nejm200007273430407 · Cited by 1,078
Mortality in COPD: role of comorbidities
Sin, D. D., Anthonisen, N. R., Soriano, J. B., & Agusti, A. G. (2006) · European Respiratory Journal · doi:10.1183/09031936.00133805 · Cited by 1,052
Analysis of the lung microbiome in the “healthy” smoker and in COPD.
Erb-Downward, J. R., Thompson, D. L., Han, M. K., Freeman, C. M., McCloskey, L., Schmidt, L. A., Young, V. B., Toews, G. B., Curtis, J. L., Sundaram, B., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0016384 · Cited by 973
Chronic obstructive pulmonary disease and cardiovascular risk: Insights from the NAVIGATOR trial
de Barros e Silva, P. G. M., Califf, R. M., Sun, J.-L., McMurray, J. J. V., Holman, R., Haffner, S., Thomas, L., & Lopes, R. D. (2014) · International Journal of Cardiology · doi:10.1016/j.ijcard.2014.07.297 · Cited by 11
Cited by
Predicting mortality from AI cardiac volumes mass and coronary calcium on chest computed tomography
Miller, R. J. H., Killekar, A., Shanbhag, A., Bednarski, B., Michalowska, A. M., Ruddy, T. D., Einstein, A. J., Newby, D. E., Lemley, M., Pieszko, K., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-46977-3 · Cited by 44
Saja, M., Younis, A., Alzahrani, L., Alkhlassi, I., Aldakhil, L., Albayyat, R., Alnasser, N., Alokla, K., Alghamdi, L., Rashed, A., et al. (2025) · International Journal of Chronic Obstructive Pulmonary Disease · doi:10.2147/copd.s509949 · Cited by 10
“50,52 Living with a chronic respiratory condition poses a physical and psychological strain on patients due to the progressive limitation it imposes on patients’ day-to-day activities, negatively impacting their HRQoL.”
Metadata
- Authors
- André, S., Conde, B., Fragoso, E., Boléo-Tomé, J. P., Areias, V., Cardoso, J., & Crónica, O. B. O. T. G. D.-G. D. I. N. D. P. O.
- Venue
- Pulmonology
- Publisher
- Informa UK Limited
- Published
- 2019-05-30
- Volume
- 25
- Issue
- 3
- Pages
- 168-176
- ISSN
- 2531-0429 (ISSN-L)
- 2531-0437
- OpenAlex
- W2905313402
- Cited by
- 185
- References
- 4
- FWCI
- 4.90
- Type
- journal article
- Language
- en
- Open access
- diamond
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: COPD and Cardiovascular Disease. https://app.cochat.ai/papers/10.1016/j.pulmoe.2018.09.006
- The paper
- André, S., Conde, B., Fragoso, E., Boléo-Tomé, J. P., Areias, V., Cardoso, J., & Crónica, O. B. O. T. G. D.-G. D. I. N. D. P. O. (2019). COPD and Cardiovascular Disease. Pulmonology. https://doi.org/10.1016/j.pulmoe.2018.09.006
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.